The FDA approved revumenib for the treatment of certain patients with advanced acute leukemia.The indication applies to use of the agent by adults or by children aged at least 1 year who have relapsed or refractory disease and a lysine methyltransferase 2A gene (KMT2A) translocation, a genetic alteration associated with poor prognosis.
CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart…
During assessments of episodic memory, processing speed, and inhibition and attention, children with vs. without asthma had poorer scores, according to results published in JAMA…
SAN ANTONIO — Obesity medications, regardless of class or generation, were associated with reduced alcohol intake among individuals participating in a telehealth weight-loss program, a…
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality
The latest news from the ACR Annual Meeting, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Among adult smokers who moved from smoking cigarettes to e-cigarettes exclusively, wheeze resolution went up, but this was not the case if they moved to…
Breast cancer experts from Ohio State and invited speakers will bring you the latest insights and practical guidance as presented at the 2024 San Antonio…
Panelists discuss the key advice they would offer to fellow physicians, nurse practitioners, advanced practice providers, and pharmacists involved in the care of patients on…
The latest news from the ACR Annual Meeting, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Panelists discuss how to approach selecting first-line treatment options for hormone receptor–positive, HER2-negative advanced breast cancer by providing an overview of standard-of-care options and highlighting…
